Showing results (21-30 of 143) with videos related to
Sort By:
Pageof 15
Critical Care Medicine|July 1, 1984
Glucagon: hormone or therapeutic agent?K Hall-Boyer, G P Zaloga, B ChernowHeart & Lung : the Journal of Critical Care|July 1, 1984
Endogenous opioid peptides: critical care implicationsG P Zaloga, C Hostinsky, B ChernowThe Psychiatric Clinics of North America|December 1, 1984
Psychopharmacology in the intensive care unitW Boyer, B Chernow, C R LakeCirculatory Shock|January 1, 1986
Hepatic alpha 1-adrenergic receptor alteration in a rat model of chronic sepsisM McMillan, B Chernow, B L RothCanadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 1, 1987
Cyclothymic disorder and bromocriptine: predisposing factors for postpartum mania?C R Lake, A Reid, C Martin, et al.AACN Clinical Issues|May 1, 1996
Blood conservation in acute care and critical careB Chernow, E Jackson, J A Miller, et al.The Journal of Clinical Endocrinology and Metabolism|May 1, 1987
Free fatty acids alter calcium binding: a cause for misinterpretation of serum calcium values and hypocalcemia in critical illnessG P Zaloga, S Willey, P Tomasic, et al.Life Sciences|August 4, 1986
Glucagon is an antagonist of morphine bradycardia and antinociceptionD Malcolm, G Zaloga, B Chernow, et al.Critical Care Medicine|January 1, 1995
Progressive magnesium deficiency increases mortality from endotoxin challenge: protective effects of acute magnesium replacement therapyM Salem, N Kasinski, R Munoz, et al.Critical Care Medicine|November 21, 1997
Use of different anticoagulants in test tubes for analysis of blood lactate concentrations: Part 2. Implications for the proper handling of blood specimens obtained from critically ill patientsJ Wiese, A Didwania, R Kerzner, et al.Pageof 15